The STOP-HPV Scale-Up Study
STOP-HPV 扩大研究
基本信息
- 批准号:10564651
- 负责人:
- 金额:$ 64.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:17 year oldAddressAdolescentAdoptionAmericanCessation of lifeChildhoodClinical Nurse SpecialistsCommunicationEffectivenessEligibility DeterminationEvaluationEvidence based practiceFeedbackGoalsHealthHealth systemHuman Papilloma Virus VaccinationHuman Papilloma Virus VaccineHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusLearningLogicMaintenanceMalignant NeoplasmsMedicalMedical Care CostsMethodsModelingMorbidity - disease rateOutcomeParentsPopulationPractical Robust Implementation and Sustainability ModelProceduresProcessProviderQualitative MethodsRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceReadinessResearchSeriesSurvey MethodologySystemTechniquesTelephoneTestingTrainingVaccinationVaccinesarmcollaborative carecompare effectivenesscostcost effectivecost effectivenessdesigneffectiveness evaluationhealth assessmenthealth organizationhealth trainingimplementation processimplementation scienceimplementation strategyimprovedinterestorganizational readinesspoint of carepractice factorspreventprimary care practiceprimary outcomeprovider communicationprovider factorsrecruitscale upsecondary outcometreatment as usualuptakevaccination outcomevaccine acceptancevaccine deliveryvaccine hesitancyvaccine strategy
项目摘要
Abstract
Human papillomavirus (HPV) causes 33,700 US cancer cases per year, 4,000 deaths and $4 billion in cancer-
related medical costs. Despite an effective vaccine, in 2020 less than 60% of US adolescents 13-17 years of
age completed their HPV vaccine series. Key barriers are suboptimal clinician communication to address
parental vaccine hesitancy, and ineffective office systems causing missed opportunities for vaccination.
Our research team tested two promising implementation strategies (ISs) in primary care practices to address
these barriers: online clinician communication training (“STOP-HPV-Online”) which trains clinicians on
communication techniques and addresses parent hesitancy, and a multi-component IS (“STOP-HPV-LC”) that
involves both clinician communication training plus office-based changes in workflow learned on monthly learning
collaborative group phone calls. Both ISs were deployed by our research team. Widespread scalability requires
the ISs to be deployed by health systems since most primary care practices are now part of health systems.
For Aim 1 we will adapt the two ISs for deployment by 8 health systems, and also describe baseline strategies
used by these systems. We will partner with the American Medical Group Association® (AMGA),the main national
organization of health systems. More than 8 health systems have already expressed interest in the study. We
will use a mixed-methods approach and the RE-Aim/PRISM framework to evaluate the effectiveness and
implementation processes of the health-system deployed implementation strategies. We will assess how health
systems deploy core IS functions and how they and practices adapt specific activities (forms) within each IS.
Aims 2-3 will use a 3-arm clustered RCT, randomizing 72 practices within the 8 health systems to STOP-HPV-
Online, STOP-HPV-LC, or usual care control. Aim 2 will compare the effectiveness and cost-effectiveness of
the two ISs to control and to each other over a 12-month IS period and another 12-month maintenance period.
The primary outcome for Aim 2 is HPV vaccine initiation; secondary outcomes are vaccine series completion
and cost-effectiveness of the IS.
Aim 3 will assess provider, practice, and health system factors relevant to implementation of the two ISs. The
primary outcome is adoption (uptake of core IS functions such as clinicians completing the online modules);
secondary outcomes include reach (e.g., % clinicians participating), practice/provider factors (e.g.,
organizational readiness) associated with improvement in rates, and maintenance of core IS functions by
practices over 12 additional months. We will develop and disseminate online implementation guides for health
systems and practices to use, and AMGA will help spread the ISs to their other health systems.
By the end of the study, we will have two scalable ISs for AMGA and any health system to improve HPV
vaccination rates and reduce HPV-related cancers.
摘要
人乳头瘤病毒(HPV)每年导致33,700例美国癌症病例,4,000例死亡和40亿美元的癌症-
相关医疗费用。尽管有有效的疫苗,但到2020年,13-17岁的美国青少年中只有不到60%的人
年龄完成了他们的HPV疫苗系列。关键障碍是有待解决的临床医生沟通欠佳
父母对接种疫苗犹豫不决,以及无效的办公系统导致错过接种疫苗的机会。
我们的研究团队在初级保健实践中测试了两种有希望的实施策略(IS),以解决
这些障碍:在线临床医生沟通培训(“STOP-HPV-Online”)
通信技术和解决父母犹豫,以及多组分IS(“STOP-HPV-LC”),
涉及临床医生沟通培训以及每月学习中学习的工作流程中基于办公室的变化
协作组电话。这两个IS都是由我们的研究团队部署的。广泛的可扩展性要求
卫生系统将部署信息系统,因为大多数初级保健实践现在是卫生系统的一部分。
对于目标1,我们将调整这两个IS以供8个卫生系统部署,并描述基线策略
使用这些系统。我们将与美国医疗集团协会(AMGA)合作,该协会是美国主要的国家医疗机构。
卫生系统的组织。超过8个卫生系统已经表示对这项研究感兴趣。我们
将使用混合方法和RE-Aim/PRISM框架来评估有效性,
卫生系统的实施进程部署了实施战略。我们将评估健康
系统部署核心IS功能,以及它们和实践如何适应每个IS中的特定活动(形式)。
目标2-3将使用3组随机对照试验,在8个卫生系统内随机选择72个实践,以阻止HPV-
在线、STOP-HPV-LC或常规护理控制。目标2将比较以下方法的有效性和成本效益:
两个IS在12个月的IS期和另一个12个月的维护期内相互控制和相互连接。
目标2的主要结局是HPV疫苗的启动;次要结局是疫苗系列的完成
和成本效益。
目标3将评估与两个IS实施相关的提供者、实践和卫生系统因素。的
主要结果是采用(核心IS功能的吸收,例如完成在线模块的临床医生);
次要结果包括到达(reach)(例如,参与的临床医生百分比),实践/提供者因素(例如,
组织准备)与提高费率有关,并通过以下方式维持核心信息系统职能:
在12个月的额外实践中。我们将制定和传播在线卫生执行指南,
AMGA将帮助将IS推广到其他卫生系统。
到研究结束时,我们将为AMGA和任何卫生系统提供两个可扩展的IS,以改善HPV
疫苗接种率和减少HPV相关癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER G SZILAGYI其他文献
PETER G SZILAGYI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER G SZILAGYI', 18)}}的其他基金
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
通过电子健康记录患者门户改善整个卫生系统的流感疫苗接种
- 批准号:
10319923 - 财政年份:2018
- 资助金额:
$ 64.08万 - 项目类别:
National Immunization Partnership with the APA (NIPA)
与 APA 的国家免疫合作伙伴关系 (NIPA)
- 批准号:
8916858 - 财政年份:2014
- 资助金额:
$ 64.08万 - 项目类别:
National Immunization Partnership with the APA (NIPA)
与 APA 的国家免疫合作伙伴关系 (NIPA)
- 批准号:
8931758 - 财政年份:2014
- 资助金额:
$ 64.08万 - 项目类别:
National Partnership for Adolescent Immunization
国家青少年免疫合作伙伴关系
- 批准号:
8495004 - 财政年份:2012
- 资助金额:
$ 64.08万 - 项目类别:
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
学校为儿童接种流感疫苗:社区范围内的传播
- 批准号:
8266976 - 财政年份:2012
- 资助金额:
$ 64.08万 - 项目类别:
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
学校为儿童接种流感疫苗:社区范围内的传播
- 批准号:
8897991 - 财政年份:2012
- 资助金额:
$ 64.08万 - 项目类别:
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
学校为儿童接种流感疫苗:社区范围内的传播
- 批准号:
8551623 - 财政年份:2012
- 资助金额:
$ 64.08万 - 项目类别:
National Partnership for Adolescent Immunization
国家青少年免疫合作伙伴关系
- 批准号:
8705921 - 财政年份:2012
- 资助金额:
$ 64.08万 - 项目类别:
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
学校为儿童接种流感疫苗:社区范围内的传播
- 批准号:
8708812 - 财政年份:2012
- 资助金额:
$ 64.08万 - 项目类别:
National Partnership for Adolescent Immunization
国家青少年免疫合作伙伴关系
- 批准号:
8529214 - 财政年份:2012
- 资助金额:
$ 64.08万 - 项目类别:
相似海外基金
Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
- 批准号:
10608426 - 财政年份:2023
- 资助金额:
$ 64.08万 - 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
- 批准号:
486580 - 财政年份:2022
- 资助金额:
$ 64.08万 - 项目类别:
Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
- 批准号:
MR/V032380/1 - 财政年份:2022
- 资助金额:
$ 64.08万 - 项目类别:
Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/1 - 财政年份:2021
- 资助金额:
$ 64.08万 - 项目类别:
Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
- 批准号:
455984 - 财政年份:2021
- 资助金额:
$ 64.08万 - 项目类别:
Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/2 - 财政年份:2021
- 资助金额:
$ 64.08万 - 项目类别:
Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10057761 - 财政年份:2020
- 资助金额:
$ 64.08万 - 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10213683 - 财政年份:2020
- 资助金额:
$ 64.08万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 64.08万 - 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
- 批准号:
356145 - 财政年份:2016
- 资助金额:
$ 64.08万 - 项目类别:
Operating Grants